Key result
Non-critical COVID-19 linked to severe arterial and venous thromboembolic complications.
Why the study?
The occurrence of both arterial and venous thrombotic complications in patients with COVID-19 has been receiving increasing attention but requires further clinical characterization.
Case Report (n=3)
Highlights the occurrence of arterial and venous thrombotic complications in COVID-19 patients, urging physician vigilance.
May support vigilance for thromboembolism in non-critically ill COVID-19; leaves open optimal prophylaxis strategies.
Coronavirus Disease 2019 (COVID-19) has had an enormous impact on both the medical community as well as society as a whole. Research on the pathogenesis and the treatment of the disease is rapidly emerging, with new observations and hypotheses appearing daily. One aspect that has been receiving increasing attention is the occurrence of both arterial and venous thrombotic complications in patients with COVID-19. We report three cases of thromboembolic complications in patients affected by COVID-19 and discuss clinical features, pathophysiology, and the proposed approaches to management of vascular complications in these patients. Through our discussion, we also urge physicians to be vigilant for any symptoms or signs suggestive of thrombosis in patients with COVID-19.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2022) conducted a case report in COVID-19 (n=3). COVID-19 was evaluated on Thromboembolic complications. Three patients with COVID-19 developed severe arterial and venous thromboembolic complications, including stroke, pulmonary embolism, and deep vein thrombosis, despite not being critically ill.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: